Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Multiple Sclerosis and Related Disorders|January 10, 2022
Monitoring of safety and effectiveness of cladribine in multiple sclerosis patients over 50 yearsGiulio Disanto, Marcello Moccia, Rosaria Sacco, et al.Journal of Neurology|April 17, 2024
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implicationsAntonio Luca Spiezia, Giulia Scalia, Maria Petracca, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 17, 2023
Concomitant diagnosis of multiple sclerosis and human immunodeficiency virus (HIV) infection: case report and the review of literatureAssunta Trinchillo, Antonio Luca Spiezia, Antonio Carotenuto, et al.Multiple Sclerosis and Related Disorders|July 27, 2024
Being highly sensitive person negatively impacts on cognitive and psychosocial fatigue in multiple sclerosis patients: A cross-sectional, monocenter studyFabrizia Falco, Federica Lamagna, Antonio Esposito, et al.Multiple Sclerosis and Related Disorders|October 14, 2023
Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosisAntonio Luca Spiezia, Fabrizia Falco, Andrea Manganelli, et al.Journal of Clinical Medicine|December 24, 2021
Retinal and Choriocapillary Vascular Changes in Early Stages of Multiple Sclerosis: A Prospective StudyDaniela Montorio, Roberta Lanzillo, Antonio Carotenuto, et al.International Journal of Molecular Sciences|December 11, 2022
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of LiteratureAntonio Luca Spiezia, Antonio Carotenuto, Aniello Iovino, et al.Journal of Neurology|September 1, 2022
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational studyNicola Capasso, Raffaele Palladino, Vincenza Cerbone, et al.European Journal of Neurology|October 30, 2024
Association between CD20+ T lymphocytes and neuropsychological findings in multiple sclerosisAntonio Esposito, Fabrizia Falco, Giulia Scalia, et al.Toxins|November 10, 2022
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple SclerosisFederica Novarella, Antonio Carotenuto, Paolo Cipullo, et al.Pageof 3